Edwards MR, Saglani S, Schwarze J, Skevaki C, Smith JA, Ainsworth B, Almond M, Andreakos E, Belvisi MG, Chung KF, et al: Addressing unmet needs in understanding asthma mechanisms: From the European Asthma Research and Innovation Partnership (EARIP) Work Package (WP)2 collaborators
Note that the therapeutic indication for all of these drugs is for type 2 diabetes, with the exception of Wegovy (2.4 mg/week of semaglutide by subcutaneous injection), which was recently approved for weight loss
Ron, D., Luo, J., and Mochly-Rosen, D
5 days), is partially metabolized and excreted via the biliary route, and exerts a stronger weight-reducing effect
Chronic alcohol abuse reduces glutathione in the liver
GLP-1s are still relatively new in the way theyre being used now, and we simply dont have enough data to understand their full impact over time especially in younger populations or those using them off-label